(VIANEWS) – Shares of ImmunoGen (NASDAQ: IMGN) jumped by a staggering 20.4% in 14 days from $4.51 to $5.43 at 20:27 EST on Friday, following the last session’s upward trend. NASDAQ is jumping 2.09% to $13,047.19, following the last session’s upward trend.
ImmunoGen’s last close was $5.43, 30.12% under its 52-week high of $7.77.
Today’s last reported volume for ImmunoGen is 6440324 which is 81.05% above its average volume of 3557198.
ImmunoGen’s sales growth is a negative 4.5% for the ongoing quarter and 39.7% for the next. The company’s growth estimates for the present quarter and the next is a negative 46.7% and a negative 38.9%, respectively.
Year-on-year quarterly revenue growth declined by 67.4%, now sitting on 69.86M for the twelve trailing months.
ImmunoGen’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.72%, a negative 0.12%, and a positive 3.86%, respectively.
ImmunoGen’s highest amplitude of average volatility was 2.10% (last week), 3.40% (last month), and 3.86% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
ImmunoGen’s stock is considered to be overbought (>=80).
ImmunoGen’s Stock Yearly Top and Bottom Value
ImmunoGen’s stock is valued at $5.43 at 20:27 EST, way below its 52-week high of $7.77 and way higher than its 52-week low of $3.10.
ImmunoGen’s Moving Average
ImmunoGen’s worth is way higher than its 50-day moving average of $4.32 and above its 200-day moving average of $5.33.
More news about ImmunoGen (IMGN).